Abacavir hypersensitivity: a model system for pharmacogenetic test adoption (Q37353680)

19 August 2017

1 reference

title

Abacavir hypersensitivity: a model system for pharmacogenetic test adoption (English)

1 reference

19 August 2017

1 reference

Myla Lai-Goldman

1

1 reference

19 August 2017

Hawazin Faruki

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

12

1 reference

19 August 2017

874-878

1 reference

https://scigraph.springernature.com/pub.10.1097/gim.0b013e31818de71c

19 August 2017

0 references

cites work

HLA-B*5701 screening for hypersensitivity to abacavir

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

HLA-B*5701 clinical testing: early experience in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Maraviroc: integration of a new antiretroviral drug class into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E31818DE71C

10.1097/GIM.0B013E31818DE71C

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference